Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aria Sepahan Pharmaceutical is an Iranian pharmaceutical company headquartered in Isfahan that specializes in the production of finished dosage forms. The company focuses on the manufacturing of generic medications across a broad spectrum of therapeutic areas, including cardiovascular, gastrointestinal, and neurological health. Operating with a commitment to international quality standards, Aria Sepahan utilizes modern manufacturing facilities to produce oral solids such as tablets and capsules. The firm plays a significant role in the domestic Iranian healthcare market by providing affordable access to essential medicines. Its business model encompasses the entire value chain from formulation development to large-scale commercial production and distribution. The company maintains a strong focus on research and development to expand its portfolio of generic offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aria Sepahan Pharmaceutical.